NDC 55150-293 – Glycopyrrolate
Glycopyrrolate .2 mg/mL · Injection, Solution · Intramuscular, Intravenous
Product NDC55150-293
Product details
- Brand name
- Glycopyrrolate
- Generic name
- Glycopyrrolate
- Labeler
- AuroMedics Pharma LLC
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Intravenous
- Marketing category
- ANDA · ANDA210244
- Marketed since
- November 28, 2018
- Listing expires
- December 31, 2026
- Pharmacologic class
- Anticholinergic
Active ingredients
- Glycopyrrolate .2 mg/mL
Uses, dosage, side effects and warnings for Glycopyrrolate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 55150-293-02 | 25 VIAL, SINGLE-DOSE in 1 CARTON (55150-293-02) / 2 mL in 1 VIAL, SINGLE-DOSE | Nov 28, 2018 |
Recalls mentioning this NDC
- D-0853-2020 Feb 26, 2020 · Class III
Failed Impurities/Degradation Specifications: elevated levels of Benzaldehyde impurity was found in investigative samples (retain samples).
Other Glycopyrrolate products
- 0517-4620 Glycopyrrolate .2 mg/mL · Injection, Solution · American Regent, Inc.
- 0517-4605 Glycopyrrolate .2 mg/mL · Injection, Solution · American Regent, Inc.
- 0517-4602 Glycopyrrolate .2 mg/mL · Injection, Solution · American Regent, Inc.
- 0517-4601 Glycopyrrolate .2 mg/mL · Injection, Solution · American Regent, Inc.
- 70121-1698 Glycopyrrolate .2 mg/mL · Injection, Solution · Amneal Pharmaceuticals LLC
- 70121-1699 Glycopyrrolate .2 mg/mL · Injection, Solution · Amneal Pharmaceuticals LLC
- 55150-295 Glycopyrrolate .2 mg/mL · Injection, Solution · AuroMedics Pharma LLC
- 55150-294 Glycopyrrolate .2 mg/mL · Injection, Solution · AuroMedics Pharma LLC
- 55150-292 Glycopyrrolate .2 mg/mL · Injection, Solution · AuroMedics Pharma LLC
- 72572-226 Glycopyrrolate .2 mg/mL · Injection, Solution · Civica, Inc.
- 63323-578 Glycopyrrolate .2 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 65219-801 Glycopyrrolate .2 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC